TMDX
TransMedics GroupANasdaq / Health Care Equipment & Services
Last Price
At close
2026-08-03
Current thesis
Bull: successful commercial expansion, improved reimbursement, and rising procedure volumes validate pricing and drive sustained double‑digit revenue growth.
Posture
Constructive
Lead driver
Sentiment
What changed
Next scheduled catalyst: earnings 2026-08-04 · AMC.
What can break
Earnings/guidance miss
Momentum
16
Value
58
Sentiment
86
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $144.75 · Bull $170.00 · Bear $114.00
Earnings
2026-08-04 · AMC
Data freshness
Prices
As of 2026-08-03
Fundamentals
As of 2026-08-03 • Vendor: Data Vendor v1
Scores
As of 2026-08-03 • Model: HYBRID_IC_RP
AI Memo
As of 2026-02-25 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-08-03
Investment thesis
As of 2026-08-03
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $106.00
Why
Momentum16 · Δ7d +5.7
Value58 · Δ7d -0.6
Sentiment86 · Δ7d 0.0
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Sentiment · See AI snapshot
Momentum
16
10% active weight
Current posture
7d trendImproving
Δ7d
+5.7
Δ21d
+11.8
Value
58
40% active weight
Current posture
7d trendFlat
Δ7d
-0.6
Δ21d
-0.5
Sentiment
86
49% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
0.0
Why this grade
Composite grade A. Momentum 16.3 / Value 58.0 / Sentiment 85.6
Fundamentals (TTM)As of 2026-08-03
Fundamentals (TTM)
As of 2026-08-03
Market Cap
$2.82B
Beta
2.04
Shares Out
34.56M
P/E (TTM)
53.0
P/S (TTM)
7.62
P/FCF (TTM)
35.77
Rev YoY
+21.2%
EPS YoY
-71.2%
Gross Margin
+58.8%
Op Margin
+16.9%
Net Debt
$30.91M
Current Ratio
6.74
As of 2026-08-03 • Updated nightlySource: Internal modelMethodology